Invention Application
- Patent Title: O-GLCNACYLATED PROTEIN-LIKE SUBSTANCE AND FIBROSIS THERAPEUTIC DRUG CONTAINING SAME
-
Application No.: US17775864Application Date: 2020-11-13
-
Publication No.: US20220389047A1Publication Date: 2022-12-08
- Inventor: Hirohiko ISE , Saori MATSUO
- Applicant: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION , SOMAR CORPORATION
- Applicant Address: JP Fukuoka; JP Tokyo
- Assignee: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION,SOMAR CORPORATION
- Current Assignee: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION,SOMAR CORPORATION
- Current Assignee Address: JP Fukuoka; JP Tokyo
- Priority: JP2019-206265 20191114
- International Application: PCT/JP2020/042362 WO 20201113
- Main IPC: C07H15/26
- IPC: C07H15/26 ; A61P17/02
Abstract:
An O-GlcNAcylated protein-like substance having an N-acetylglucosamine unit, and at least one unit selected from the group consisting of a carboxy group-containing radically polymerizable unit, a styrene unit, a polyethylenimine unit, a poly-L-lysine unit, and a biotin unit; and a fibrosis therapeutic drug containing the O-GlcNAcylated protein-like substance.
Information query
